Double Bond Pharmaceutical International AB
DBP B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007185517 (+1 more)
- LEI:
- 254900U1MWE2YSPREX74
- Country:
- Sweden
- Address:
- Virdings Alle 32B, 754 50 Uppsala
- Website:
- https://www.doublebp.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Swedish Orphan Biovitrum | Sweden | SOBI | |
|
SynAct Pharma | Sweden | SYNACT | |
|
SYNAIRGEN PLC | United Kingdom | SNG | |
|
Synthaverse S.A. | Poland | BML | |
|
Taurus Energy AB | Sweden | TAUR B | |
| Themis GREN Ltd. | Israel | TMIS | ||
|
Theradiag | France | ALTER | |
|
Theranexus | France | ALTHX | |
|
Thor Medical ASA | Norway | NANOV | |
|
TME Pharma N.V. | Germany | ALTME |